RESUMO
A rational approach that may be applied to a broad class of enzyme-catalyzed reactions to design enzyme inhibitors affords a powerful strategy, facilitating the development of drugs and/or molecular probes of enzyme mechanisms. A strategy for the development of substrate-product analogues (SPAs) as inhibitors of racemases and epimerases is elaborated using isoleucine 2-epimerase from Lactobacillus buchneri (LbIleE) as a model enzyme. LbIleE catalyzes the PLP-dependent, reversible, racemization or epimerization of nonpolar amino acids at the C-2 position. The enzyme plays an important role in the biosynthesis of branched-chain d-amino acids and is a potential target for the development of antimicrobial agents. 3-Ethyl-3-methyl-l-norvaline (Ki = 2.9 ± 0.2 mM) and 3-ethyl-3-methyl-d-norvaline (Ki = 1.5 ± 0.2 mM) were designed as SPAs based on the movement of the sec-butyl side chain of the substrate l-Ile during catalysis, and were competitive inhibitors with binding affinities exceeding that of l-Ile by 1.3- and 2.5-fold, respectively. Surprisingly, these compounds were not substrates, but the corresponding compounds lacking the 3-methyl group were substrates. Unlike serine, glutamate, and proline racemases, which exhibit stringent steric requirements at their active sites, the active site of LbIleE was amenable to binding bulky SPAs. Moreover, LbIleE bound the SPA 2,2-di-n-butylglycine (Ki = 11.0 ± 0.2 mM) as a competitive inhibitor, indicating that the hydrophobic binding pocket at the active site was sufficiently plastic to tolerate gem-dialkyl substitution at the α-carbon of an amino acid. Overall, these results reveal that amino acid racemases/epimerases are amenable to inhibition by SPAs provided that they possess a capacious active site.
Assuntos
Desenho de Fármacos , Inibidores Enzimáticos/farmacologia , Glicina/farmacologia , Isoleucina/antagonistas & inibidores , Lactobacillus/enzimologia , Racemases e Epimerases/antagonistas & inibidores , Valina/análogos & derivados , Sítios de Ligação/efeitos dos fármacos , Biocatálise/efeitos dos fármacos , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Glicina/análogos & derivados , Glicina/química , Isoleucina/metabolismo , Modelos Moleculares , Conformação Molecular , Racemases e Epimerases/metabolismo , Especificidade por Substrato , Valina/síntese química , Valina/química , Valina/farmacologiaRESUMO
A recent push to provide more translationally relevant preclinical models for examination of pharmacological mechanisms underlying inhaled substances of abuse has resulted in the development of equipment and methods that allows exposure of freely moving rodents to aerosolized psychoactive drugs. In the present study, synthetic cannabinoids (CP55,940, AB-CHMINACA, and AMB-FUBINACA) were administered intraperitoneally (i.p.) or aerosolized via a modified electronic cigarette device. Subsequently, the compounds were evaluated in adult male and female C57/Bl6 mice trained to discriminate i.p. 5.6 mg/kg Δ9-tetrahydrocannabinol (THC) for food reinforcement. When administered i.p., THC and AB-CHMINACA were equally potent at producing THC-like effects in both sexes, but CP55,940 and AMB-FUBINACA were more potent in males. Upon aerosol exposure, all compounds continued to produce THC-like effects in both sexes, with AMB-FUBINACA remaining the most potent. In contrast, aerosolized CP55,940 showed substantial decreases in potency in both sexes. Aerosolized nicotine did not substitute for THC in either sex. In females, aerosolized cumyl-4CN-BINACA produced concentration-dependent increases in responding on the THC-associated nosepoke. In addition, the effects of an active concentration of AMB-FUBINACA were reversed by rimonabant, suggesting CB1 receptor mediation. These results show that synthetic cannabinoids produce THC-like effects when injected i.p. or after aerosolization. This study adds to a growing literature suggesting that evaluation of abuse liability of substances via aerosol exposure is feasible and may provide a translationally relevant method that allows for investigation of factors important to the abuse of drugs which humans typically smoke or vape.
Assuntos
Comportamento Animal/efeitos dos fármacos , Canabinoides/administração & dosagem , Condicionamento Operante/efeitos dos fármacos , Cicloexanóis/administração & dosagem , Sistemas Eletrônicos de Liberação de Nicotina , Indazóis/administração & dosagem , Valina/análogos & derivados , Vaping , Administração por Inalação , Aerossóis , Animais , Canabinoides/síntese química , Cicloexanóis/síntese química , Feminino , Indazóis/síntese química , Injeções Intraperitoneais , Masculino , Camundongos Endogâmicos C57BL , Valina/administração & dosagem , Valina/síntese químicaRESUMO
The antifungal activity of 5-hydroxy-4-oxo-l-norvaline (HONV), exhibited under conditions mimicking human serum, may be improved upon incorporation of this amino acid into a dipeptide structure. Several HONV-containing dipeptides inhibited growth of human pathogenic yeasts of the Candida genus in the RPMI-1640 medium, with minimal inhibitory concentration values in the 32 to 64 µg mL-1 range. This activity was not affected by multidrug resistance that is caused by overexpression of genes encoding drug efflux proteins. The mechanism of antifungal action of HONV dipeptides involved uptake by the oligopeptide transport system, subsequent intracellular cleavage by cytosolic peptidases, and inhibition of homoserine dehydrogenase by the released HONV. The relative transport rates determined the anticandidal activity of HONV dipeptides.
Assuntos
Antifúngicos/farmacologia , Candida albicans/efeitos dos fármacos , Candida albicans/enzimologia , Dipeptídeos/farmacologia , Inibidores Enzimáticos/farmacologia , Homosserina Desidrogenase/antagonistas & inibidores , Valina/análogos & derivados , Valina/farmacologia , Antifúngicos/síntese química , Antifúngicos/química , Dipeptídeos/síntese química , Dipeptídeos/química , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/química , Homosserina Desidrogenase/metabolismo , Testes de Sensibilidade Microbiana , Conformação Molecular , Relação Estrutura-Atividade , Valina/síntese química , Valina/químicaRESUMO
Novel l-valinate amide benzoxaboroles and analogues were designed and synthesized for a structure-activity-relationship (SAR) investigation to optimize the growth inhibitory activity against Trypanosoma congolense (T. congolense) and Trypanosoma vivax (T. vivax) parasites. The study identified 4-fluorobenzyl (1-hydroxy-7-methyl-1,3-dihydrobenzo[c][1,2]oxaborole-6-carbonyl)-l-valinate (5, AN11736), which showed IC50 values of 0.15â¯nM against T. congolense and 1.3â¯nM against T. vivax, and demonstrated 100% efficacy with a single dose of 10â¯mg/kg against both T. congolense and T. vivax in mouse models of infection (IP dosing) and in the target animal, cattle, dosed intramuscularly. AN11736 has been advanced to early development studies.
Assuntos
Antiprotozoários/síntese química , Compostos de Boro/síntese química , Tripanossomíase Africana/tratamento farmacológico , Valina/análogos & derivados , Animais , Antiprotozoários/farmacologia , Antiprotozoários/uso terapêutico , Compostos de Boro/farmacologia , Compostos de Boro/uso terapêutico , Bovinos , Camundongos , Relação Estrutura-Atividade , Trypanosoma congolense/efeitos dos fármacos , Trypanosoma vivax/efeitos dos fármacos , Tripanossomíase Africana/patologia , Tripanossomíase Africana/veterinária , Valina/síntese química , Valina/farmacologia , Valina/uso terapêuticoRESUMO
Concise total syntheses of smenothiazoles A (1) and B (2), two distinguished vinyl chloride containing natural products isolated from the marine sponge S. aurea, have been developed. Silastannation, Stille reaction and a carefully controlled desilylchlorination were employed as key steps to construct unique polyketide acid fragments, and the optimized reaction conditions avoided migration of 2,5-diene to a 2,4-conjugated system. This report unambiguously confirmed the structures of both natural products.
Assuntos
Tiazóis/síntese química , Valina/análogos & derivados , Alcinos/química , Estereoisomerismo , Tiazóis/química , Valina/síntese química , Valina/químicaRESUMO
Fractionation of the bioactive CHCl3-MeOH (1:1) extracts obtained from two collections of the sponge consortium Plakortis symbiotica-Xestospongia deweerdtae from Puerto Rico provided two new plakinidone analogues, designated as plakinidone B (2) and plakinidone C (3), as well as the known plakinidone (1), plakortolide F (4), and smenothiazole A (5). The structures of 1-5 were characterized on the basis of 1D and 2D NMR spectroscopic, IR, UV, and HRMS analysis. The absolute configurations of plakinidones 2 and 3 were established through chemical correlation methods, VCD/ECD experiments, and spectroscopic data comparisons. When assayed in vitro against Mycobacterium tuberculosis H37Rv, none of the plakinidones 1-3 displayed significant activity, whereas smenothiazole A (5) was the most active compound, exhibiting an MIC value of 4.1 µg/mL. Synthesis and subsequent biological screening of 8, a dechlorinated version of smenothiazole A, revealed that the chlorine atom in 5 is indispensable for anti-TB activity.
Assuntos
Antituberculosos/farmacologia , Mycobacterium tuberculosis/química , Peróxidos/farmacologia , Plakortis/química , Tiazóis/síntese química , Tiazóis/farmacologia , Valina/análogos & derivados , Xestospongia/química , Animais , Antituberculosos/síntese química , Antituberculosos/química , Produtos Biológicos , Dioxinas/síntese química , Dioxinas/química , Dioxinas/farmacologia , Lactonas/síntese química , Lactonas/química , Lactonas/farmacologia , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Mycobacterium tuberculosis/metabolismo , Peróxidos/síntese química , Peróxidos/química , Porto Rico , Tiazóis/química , Valina/síntese química , Valina/química , Valina/farmacologiaRESUMO
MMP-9 is a zinc-dependent endopeptidase that is involved in the proteolytic degradation of the extracellular matrix and plays an important role in cancer migration, invasion, and metastasis. The aim of this study was to evaluate the potential of MMP-tracers [18 F]BR420 and [18 F]BR351 for MMP-9 imaging in a colorectal cancer xenograft model. [18 F]BR420 and [18 F]BR351 were synthesized using an automated synthesis module. For [18 F]BR420, a novel and improved radiosynthesis was developed. Plasma stability and MMP-9-targeting capacity of both radiotracers was compared in the Colo205 colorectal cancer model. MMP-9 and MMP-2 expression levels in the tumors were evaluated by immunohistochemistry and in situ zymography. µPET imaging as well as ex vivo biodistribution revealed a higher tumor uptake for [18 F]BR420 (3.15% ± 0.03% ID/g vs 0.94% ± 0.18% ID/g for [18 F]BR351 at 2 hours pi) but slower blood clearance compared with [18 F]BR351. [18 F]BR351 was quickly metabolized in plasma with 20.28% ± 5.41% of intact tracer remaining at 15 minutes postinjection (PI). By contrast, [18 F]BR420 displayed a higher metabolic stability with >86% intact tracer remaining at 2 hours PI. Immunohistochemistry revealed the presence of MMP-9 and MMP-2 in the tumor tissue, which was confirmed by in situ zymography. However, an autoradiography analysis of tracer distribution in the tumors did not correlate with MMP-9 expression. [18 F]BR420 displayed a higher tumor uptake and higher stability compared with [18 F]BR351 but a low tumor-to-blood ratio and discrepancy between tracer distribution and MMP-9 immunohistochemistry. Therefore, both tracers will not be usefulness for MMP-9 imaging in colorectal cancer.
Assuntos
Neoplasias Colorretais/diagnóstico por imagem , Metaloproteinase 9 da Matriz/metabolismo , Pirimidinonas/síntese química , Compostos Radiofarmacêuticos/farmacocinética , Sulfonamidas/síntese química , Valina/análogos & derivados , Animais , Linhagem Celular Tumoral , Feminino , Radioisótopos de Flúor/química , Humanos , Taxa de Depuração Metabólica , Camundongos , Camundongos Nus , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Pirimidinonas/farmacocinética , Compostos Radiofarmacêuticos/efeitos adversos , Compostos Radiofarmacêuticos/síntese química , Sulfonamidas/farmacocinética , Distribuição Tecidual , Valina/síntese química , Valina/farmacocinéticaRESUMO
Intending to synthesize ω,ω-difluoroalkyl amino acid derivatives by oxidative desulfurization-fluorination reactions of suitable arylthio-2-phthalimido butanoates and pentanoates, in addition to small amounts of the target products, mainly α,ω-polyfluorinated amino acid derivatives were formed by additional sulfur-assisted α-fluorination. This novel structural motif was verified spectroscopically as well as by X-ray analysis. A plausible mechanism of formation is suggested. Using a different approach, δ,δ-difluoronorvaline hydrochloride was synthesized with at least 36% enantiomeric excess via deoxofluorination of the corresponding aldehyde.
Assuntos
Aminoácidos/química , Aminoácidos/síntese química , Flúor/química , Valina/análogos & derivados , Cristalografia por Raios X , Halogenação , Modelos Moleculares , Estrutura Molecular , Valina/síntese química , Valina/químicaRESUMO
Synthesis of tubuphenylalanine and tubuvaline (Tuv), α-substituted γ-amino acid building blocks for tubulysin family of antimitotic compounds, has been improved using a radical addition reaction in the presence of unprotected hydroxyl functionality. The key carbon-carbon bond construction entails stereoselective Mn-mediated photolytic additions of alkyl iodides to the C=N bond of chiral N-acylhydrazones, and generates the chiral amines in high yield with complete stereocontrol. Reductive N-N bond cleavage and alcohol oxidation converted these amino alcohols into the corresponding γ-amino acids. The route to Tuv proceeded via peptide coupling with serine methyl ester, followed by a high-yielding sequence to convert the serine amide to a thiazole. Finally, peptide bond construction established the tubulysin framework in the form of a C-terminal alcohol analog. Attempted oxidation to the C-terminal carboxylate was unsuccessful; control experiments with dipeptide 18 showed a cyclization interfered with the desired oxidation process.
Assuntos
Antimitóticos/química , Oligopeptídeos/química , Fenilalanina/análogos & derivados , Valina/análogos & derivados , Antimitóticos/síntese química , Ciclização , Oligopeptídeos/síntese química , Fenilalanina/síntese química , Estereoisomerismo , Valina/síntese químicaRESUMO
Fructosyl peptide oxidases (FPOXs) play a crucial role in the diagnosis of diabetes. Their main function is to cleave fructosyl amino acids or fructosyl peptides into glucosone and the corresponding amino acids/dipeptides. In this study, the substrate-analog FPOX inhibitors 1a-c were successfully designed and synthesized. These inhibitors mimic N(α)-fructosyl-L-valine (Fru-Val), [N(α)-fructosyl-L-valyl]-L-histidine (Fru-ValHis), and N(ε)-fructosyl-L-lysine (εFru-Lys), respectively. The secondary nitrogen atom in the natural substrates, linking fructose and amino acid or dipeptide moieties, was substituted in 1a-c with a sulfur atom to avoid enzymatic cleavage. Kinetic studies revealed that 1a-c act as competitive inhibitors against an FPOX obtained from Coniochaeta sp., and Ki values of 11.1, 66.8, and 782 µM were obtained for 1a-c, respectively.
Assuntos
Aminoácido Oxirredutases/antagonistas & inibidores , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Lisina/análogos & derivados , Valina/análogos & derivados , Aminoácido Oxirredutases/metabolismo , Ascomicetos/enzimologia , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/química , Cinética , Lisina/síntese química , Lisina/química , Lisina/farmacologia , Estrutura Molecular , Relação Estrutura-Atividade , Valina/síntese química , Valina/química , Valina/farmacologiaRESUMO
N-((R)-1-((S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl)-3-methyl-1-oxobutan-2-yl)-3-sulfamoylbenzamide is a potent C-C chemokine receptor 1 (CCR1) antagonist. The compound, possessing benzamide functionality, successfully underwent tritium/hydrogen (T/H) exchange with an organoiridium catalyst (Crabtree's catalyst). The labeling pattern in the product was studied with liquid chromatography-mass spectrometry, time-of-flight mass spectrometry, and (3) H-NMR. Overall, multiple labeled species were identified. In addition to the anticipated incorporation of tritium in the benzamide moiety, tritium labeling was observed in the valine portion of the molecule including substitution at its chiral carbon. Using authentic standards, liquid chromatography analysis of the labeled compound showed complete retention of stereochemical configuration.
Assuntos
Compostos Radiofarmacêuticos/síntese química , Receptores CCR1/antagonistas & inibidores , Sulfonamidas/síntese química , Trítio/química , Valina/análogos & derivados , Sulfonamidas/química , Valina/síntese química , Valina/químicaRESUMO
HIV protease (PR) is required for proteolytic maturation in the late phase of HIV replication and represents a prime therapeutic target. The regulation and kinetics of viral polyprotein processing and maturation are currently not understood in detail. Here we design, synthesize, validate and apply a potent, photodegradable HIV PR inhibitor to achieve synchronized induction of proteolysis. The compound exhibits subnanomolar inhibition in vitro. Its photolabile moiety is released on light irradiation, reducing the inhibitory potential by 4 orders of magnitude. We determine the structure of the PR-inhibitor complex, analyze its photolytic products, and show that the enzymatic activity of inhibited PR can be fully restored on inhibitor photolysis. We also demonstrate that proteolysis of immature HIV particles produced in the presence of the inhibitor can be rapidly triggered by light enabling thus to analyze the timing, regulation and spatial requirements of viral processing in real time.
Assuntos
Aminocumarinas/farmacologia , Carbamatos/farmacologia , Inibidores da Protease de HIV/farmacologia , Protease de HIV/química , HIV-1/efeitos dos fármacos , Precursores de Proteínas/antagonistas & inibidores , Valina/análogos & derivados , Aminocumarinas/síntese química , Sítios de Ligação , Carbamatos/síntese química , Células HEK293 , Protease de HIV/metabolismo , Inibidores da Protease de HIV/síntese química , HIV-1/fisiologia , HIV-1/efeitos da radiação , Humanos , Cinética , Luz , Modelos Moleculares , Fotólise , Ligação Proteica , Precursores de Proteínas/química , Precursores de Proteínas/metabolismo , Proteólise/efeitos dos fármacos , Fatores de Tempo , Valina/síntese química , Valina/farmacologia , Replicação ViralRESUMO
An efficient route for the synthesis of all four diastereomers of PMP-protected α-amino-γ-butyrolacton to access γ-hydroxynorvaline was established. The asymmetric key steps comprise an organocatalytic Mannich reaction and an enzymatic ketone reduction. Three reaction steps could be integrated in a one-pot process, using 2-PrOH both as solvent and as reducing agent. The sequential construction of stereogenic centres gave access to each of the four stereoisomers in high yield and with excellent stereocontrol.
Assuntos
Valina/análogos & derivados , 2-Propanol/química , Oxirredutases do Álcool/química , Oxirredutases do Álcool/metabolismo , Sítios de Ligação , Biocatálise , Butirofenonas/química , Cetonas/química , Simulação de Acoplamento Molecular , NADP/química , NADP/metabolismo , Oxirredução , Estrutura Terciária de Proteína , Substâncias Redutoras/química , Solventes/química , Estereoisomerismo , Valina/biossíntese , Valina/síntese química , Valina/químicaRESUMO
Nonstructural protein 5A (NS5A) represents a novel target for the treatment of hepatitis C virus (HCV). Daclatasvir, recently reported by Bristol-Myers-Squibb, is a potent NS5A inhibitor currently under investigation in phaseâ 3 clinical trials. While the performance of daclatasvir has been impressive, the emergence of resistance could prove problematic and as such, improved analogues are being sought. By varying the biphenyl-imidazole unit of daclatasvir, novel inhibitors of HCV NS5A were identified with an improved resistance profile against mutant strains of the virus while retaining the picomolar potency of daclatasvir. One compound in particular, methyl ((S)-1-((S)-2-(4-(4-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)quinoxalin-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate (17), exhibited very promising activity and showed good absorption and a long predicted human pharmacokinetic half-life. This compound represents a promising lead that warrants further evaluation.
Assuntos
Inibidores de Proteases/química , Quinoxalinas/química , Valina/análogos & derivados , Proteínas não Estruturais Virais/antagonistas & inibidores , Animais , Antivirais/síntese química , Antivirais/química , Antivirais/farmacocinética , Linhagem Celular , Cães , Avaliação Pré-Clínica de Medicamentos , Farmacorresistência Viral , Meia-Vida , Hepacivirus/metabolismo , Humanos , Microssomos Hepáticos/metabolismo , Inibidores de Proteases/farmacocinética , Quinoxalinas/síntese química , Quinoxalinas/farmacocinética , Ratos , Relação Estrutura-Atividade , Valina/síntese química , Valina/química , Valina/farmacocinética , Proteínas não Estruturais Virais/metabolismoRESUMO
Asymmetric hydrogenation routes to homologues of The Roche ester tend to be restricted to hydrogenations of itaconic acid derivatives, that is, substrates that contain a relatively unhindered, 1,1-disubstituted alkene. This is because in hydrogenations mediated by RhP2 complexes, the typical catalysts, it is difficult to obtain high conversions using the alternative substrate for the same product, the isomeric trisubstituted alkenes (D in the text). However, chemoselective modification of the identical functional groups in itaconic acid derivatives are difficult; hence, it would be favorable to use the trisubstituted alkene. Trisubstituted alkene substrates can be hydrogenated with high conversions using chiral analogs of Crabtree's catalyst of the type IrN(carbene). This paper demonstrates that such reactions are scalable (tens of grams) and can be manipulated to give optically pure homo-Roche ester chirons. Organocatalytic fluorination, chlorination, and amination of the homo-Roche building blocks was performed to demonstrate that they could easily be transformed into functionalized materials with two chiral centers and α,ω-groups that provide extensive scope for modifications. A synthesis of (S,S)- and (R,S)-γ-hydroxyvaline was performed to illustrate one application of the amination product.
Assuntos
Aldeídos/química , Ésteres/química , Valina/síntese química , Alcenos/química , Catálise , Hidrogenação , Estrutura Molecular , Succinatos/química , Valina/análogos & derivados , Valina/químicaRESUMO
A novel migration-addition sequence was discovered for the reaction of enantioenriched N-tert-butanesulfinyl iminoacetate 1a with functionalized benzylzinc bromide reagents, producing tert-leucine derivatives in excellent diastereoselectivity (dr 98:2). The absolute configurations of two new chiral centers were unambiguously assigned by chemical transformations and X-ray crystallography. In addition, the regio- and diastereoselectivities of this novel reaction were both explained through the key N-sulfinamine intermediate M6 generated by the tert-butyl radical attack on the imine. Computational analysis of this reaction process, which was performed at the B3LYP/6-311++G(3df,2p)//B3LYP/6-31G*-LANL2DZ level, also supported our proposed two-stage mechanism.
Assuntos
Compostos Organometálicos/química , Compostos de Sulfônio/química , Valina/análogos & derivados , Zinco/química , Cristalografia por Raios X , Radicais Livres/síntese química , Radicais Livres/química , Leucina/análogos & derivados , Modelos Moleculares , Conformação Molecular , Teoria Quântica , Estereoisomerismo , Valina/síntese química , Valina/químicaRESUMO
The objective of the present study was to develop self micro emulsifying formulation (SMEF) of valsartan to improve its oral bioavailability. The formulations were screened on the basis of solubility, stability, emulsification efficiency, particle size and zeta potential. The optimized liquid SMEF contains valsartan (20% w/w), Capmul MCM C8 (16% w/w), Tween 80 (42.66% w/w) and PEG 400 (21.33% w/w) as drug, oil, surfactant and co-surfactant, respectively. Further, Liquid SMEF was adsorbed on Aerosol 200 by spray and freeze drying methods in the ratio of 2 : 1 and transformed into free flowing powder. Both the optimized liquid and solid SMEF had the particle size <200 nm with rapid reconstitution properties. Both drying methods are equally capable for producing stable solid SMEF and immediate release of drug in in vitro and in vivo conditions. However, the solid SMEF produced by spray drying method showed high flowability and compressibility. The solid state characterization employing the FTIR, DSC and XRD studies indicated insignificant interaction of drug with lipid and adsorbed excipient. The relative bioavailability of solid SMEF was approximately 1.5 to 3.0 folds higher than marketed formulation and pure drug. Thus, the developed solid SMEF illustrates an alternative delivery of valsartan as compared to existing formulations with improved bioavailability.
Assuntos
Dessecação/métodos , Composição de Medicamentos/métodos , Liofilização/métodos , Gases/química , Tetrazóis/síntese química , Tetrazóis/farmacocinética , Valina/análogos & derivados , Administração Oral , Animais , Emulsões/administração & dosagem , Emulsões/síntese química , Masculino , Taxa de Depuração Metabólica , Tamanho da Partícula , Ratos , Ratos Sprague-Dawley , Solubilidade , Tetrazóis/administração & dosagem , Valina/administração & dosagem , Valina/síntese química , Valina/farmacocinética , ValsartanaRESUMO
A divanadium(V) complex, [V2O3(o-van-val)2] (o-van-val=Schiff base derived from o-vanillin and L-valine), has been synthesized and structurally characterized. The crystal structure shows that both of the vanadium centers in the complex have a distorted octahedral coordination environment composed of tridentate Schiff base ligand. A V2O3 core in molecular structure adopts intermediate between cis and trans configuration with the O1V1â¯V1AO1A torsion angle 115.22 (28)° and the V1â¯V1A distance 3.455Å. The binding properties of the complex with calf thymus DNA (CT-DNA) have been investigated by UV-vis absorption, fluorescence, CD spectra and viscosity measurement. The results indicate that the complex binds to CT-DNA in non-classical intercalative mode. Meanwhile, the interaction of the complex with bovine serum albumin (BSA) has been studied by UV-vis absorption, fluorescence and CD spectra. Results indicated that the complex can markedly quench the intrinsic fluorescence of BSA via a static quenching process, and cause its conformational change. The calculated apparent binding constant Kb was 1.05×10(6)M(-1) and the binding site number n was 1.18.
Assuntos
DNA/metabolismo , Substâncias Intercalantes/química , Óxidos/química , Bases de Schiff/química , Soroalbumina Bovina/metabolismo , Valina/química , Compostos de Vanádio/química , Animais , Sítios de Ligação , Bovinos , Substâncias Intercalantes/síntese química , Substâncias Intercalantes/metabolismo , Substâncias Intercalantes/farmacologia , Modelos Moleculares , Óxidos/síntese química , Óxidos/metabolismo , Óxidos/farmacologia , Ligação Proteica , Bases de Schiff/síntese química , Bases de Schiff/metabolismo , Bases de Schiff/farmacologia , Análise Espectral , Valina/síntese química , Valina/metabolismo , Valina/farmacologia , Compostos de Vanádio/síntese química , Compostos de Vanádio/metabolismo , Compostos de Vanádio/farmacologiaRESUMO
Newly synthesized acylethanolamide derivatives oleoyl-L-valinolamide (1), oleoyl-D-valinolamide (2), elaidoyl-L-valinolamide (3), elaidoyl-D-valinolamide (4) stearoyl-L-valinolamide (5), and palmitoyl-L-valinolamide (6) were investigated in mice as antiobesity compounds. Compounds 1, 2, 5, 6 significantly decreased body weight by 6.57% following eight injections of 1 mg/kg i.p. during 39 days, while 3 and 4 showed no such activity. Receptor binding indicated that no compound activated CB1, CB2, PPARα, or TRPV1 receptors. Hypothalamic RT-PCR showed that mRNA expression of the anorexigenic genes POMC and CART was up-regulated by 1, 2, 5 and 1, 2, respectively, while that of the orexigenic genes NPY and CaMKK2 was down-regulated by the respective compounds 1, 5, 6 and 1, 2, 5. Oleoyl-L-valinolamide enhances anorectic pathways and lead to decreased glucose levels, enhanced locomotor activity, and improved cognition. Effects of oleoyl-L-valinolamide on weight were dose-dependent, and it could be given orally. 1, 2, 4, 5 down-regulated FAAH mRNA expression.
Assuntos
Amidas/farmacologia , Fármacos Antiobesidade/síntese química , Peso Corporal/efeitos dos fármacos , Hipotálamo/metabolismo , Neuropeptídeo Y/antagonistas & inibidores , Ácidos Oleicos/síntese química , Pró-Opiomelanocortina/biossíntese , Valina/análogos & derivados , Animais , Fármacos Antiobesidade/farmacologia , Ingestão de Alimentos/efeitos dos fármacos , Etanolaminas/farmacologia , Feminino , Hipotálamo/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Obesos , Neuropeptídeo Y/biossíntese , Ressonância Magnética Nuclear Biomolecular , Ácidos Oleicos/farmacologia , Valina/síntese química , Valina/farmacologiaRESUMO
PepX is a X-prolyl dipeptidyl aminopeptidase of S15 family that cleaves dipeptides from the N-terminus of polypeptides having a proline or alanine residue at the second position. Involved in bacterial nutrition and in peptide maturation, this serine exopeptidase, counterpart of the mammalian DDP-4, has been proposed to play a role in pathogenicity for Streptococci and to be a promising target against trypanosomes. Searching for specific inhibitors, we undertook docking simulations on the whole surface of PepX from Lactococcus lactis, type example of the S15 family, which revealed a new putative binding site in connection with the active site and involving the C-terminal domain. Accordingly to the results of the computations, we synthesized two peptidomimetics of low molecular weight: the valinephenylpiperazine and the valine-isopropylpiperazine that can accommodate to this putative binding site. Experiments revealed that the valine-phenylpiperazine was an uncompetitive inhibitor whereas the valine-isopropylpiperazine showed to be an activator of the enzyme activity. The valine-phenylpiperazine is interacting with ASN 379, GLU 383, GLU 474, residues in connection with the specificity and active sites, and with the residues from the C-terminal domain LEU 693, GLU 710 and GLN 712. These results point out a role of the C-terminal domain in controlling access to the active site of enzymes of the S15 family, like PepX, the cocaine esterase or the alpha-amino acid ester hydrolase, and could have applications in human health giving new perspectives to struggle against streptococci or trypanosomes by designing inhibitors specific to the S15 family of enzymes.